covid-19 vaccination in mainland china covid-19 vaccination in mainland china covid-19 vaccination in mainland china is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) in mainland china, in response to the ongoing pandemic in the region. covid-19 vaccination in mainland chinacovid-19 vaccine doses administered in mainland china.date22 july 2020 (2020-07-22) – 13 april 2023 (2023-04-13)location chinacausecovid-19 pandemic in mainland chinatargetimmunization against covid-19organized byjoint prevention and control mechanism in response to the covid-19 pandemic of the state council(headquartered at national health commission)participants3,491,077,000 (total doses administered)outcome1,310,292,000 (total vaccinated)1,276,760,000 (fully vaccinated) part of a series on thecovid-19 pandemicscientifically accurate atomic model of the external structure of sars-cov-2. each "ball" is an atom. covid-19 (disease) sars-cov-2 (virus) cases deaths timeline 2019 2020 january responses february responses march responses april responses may responses june responses july responses august responses september responses october responses november responses december responses 2021 january responses february responses march responses april responses may responses june responses july responses august responses september responses october responses november responses december responses 2022 january responses february responses march responses april responses may responses june responses july responses august responses september responses october responses november december 2023 january february march april may locations by country and territory africa antarctica asia europe north america oceania south america by conveyance cruise ships naval ships international response endemic phase evacuations face masks international aid investigations into origin lockdowns by country misinformation by governments fake treatments social distancing software travel united nations world health organization wto ip waiver undercounting of deaths covid-19 apps zero-covid national responses africa china european union germany ghana india ireland netherlands new zealand nigeria philippines russia sweden uk government us federal government vietnam medical response disease testing breathalyzer development drug development drug repurposing public health mitigation vaccines history research vitt deployment authorizations operation warp speed misinformation and hesitancy us vaccine card vaccine passports current vaccines coronavac covaxin convidecia janssen medigen moderna novavax oxford–astrazeneca pfizer–biontech sinopharm bibp sputnik v variants variants of concern alpha beta gamma delta omicron other variants epsilon zeta eta theta iota kappa lambda mu cluster 5 lineage b.1.617 economic impact and recession arts and culture aviation cannabis cinema films disney fashion financial markets food industry food security journalism music performing arts retail shipping television us sportscasting programs tourism video games by country canada india ireland malaysia new zealand russia uk us by sport association football baseball basketball combat sports cricket disc golf gaelic games gridiron football ice hockey motorsport rugby league impacts animals black people crime death rates by country disability domestic violence emergency evacuations education female environment hospitals language lgbt community long-term care media coverage mental health symptoms migration military notable deaths other health issues politics diplomacy popular culture protests pregnancy prisons religion catholic church hajj science and technology social media strikes suicides telehealth xenophobia and racism society ireland malaysia new zealand russia uk us covid-19 portal wikimedia commons has media related to covid-19 vaccination in mainland china. as of july 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the population has received a booster dose. administration in june 2020, the sinopharm bibp vaccine (bbibp-corv) was authorized for emergency use in china. on july 22, chinese authorities started the emergency use of covid-19 vaccines. on december 15, 2020, the covid-19 vaccination for people under high risk started in china. on december 19, 2020, the national health commission (nhc) said that there has been 1 million doses of covid-19 vaccine administered in china as of the day, and no serious adverse reactions were observed. on december 31, 2020, nhc announced that the sinopharm bibp vaccine has been approved through the conditional marketing authorization process, and more than 3 million doses of covid-19 vaccine has been administered in china. at the same time, nhc declares that covid-19 vaccination is free to chinese citizens. on january 27, 2021, nhc said that the vaccination is being carried out in order, and there has been 22.767 million doses of covid-19 vaccine administered in china as of january 26. on march 1, 2021, zhong nanshan said that the vaccination rate of covid-19 vaccine in china was currently 3.56%, and the chinese center for disease control and prevention hoped the rate reach 40% by the end of june 2021. since late march 2021, the authorities has accelerated the promotion of free covid-19 vaccination for the whole population. on march 22, 2021, sun chunlan, the vice premier of the state council, stated that covid-19 vaccination in china should be accelerated and the vaccination rate should be increased. on march 24, 2021, nhc announced that the number doses of covid-19 vaccine administered will be daily reported on its website and social media account since that day. on march 29, 2021, nhc released the first version of the covid-19 vaccine technology guide. on april 21, 2021, nhc stated that more than 200 million doses of covid-19 vaccine has been administered in china, and 80% of doctors and nurses has been vaccinated. on may 14, 2021, nhc restated that the covid-19 administration progress should be accelerated due to the proportion of mutated sars-cov-2 and the re-appearance of local cases. on june 19, 2021, nhc announced that more than 1.01489 billion doses of covid-19 vaccine has been administered in china. while public authorities have mandated lockdowns and mandatory mass testing for areas with infection, there has not been any rule to making vaccination mandatory. some facilities within china have made vaccination mandatory for entry, including things like movie theatres, fitness centres, internet bars, museums and libraries. in july 2022, according to official figures, while 89% had received 2 doses, only 56% of eligible people had received a booster dose. furthermore, this was even lower among vulnerable elderly age groups, with only 19.7% of people over the age of 80 having received a booster dose. according to bbc reporting, this may have been attributed to public confidence in the ability of authorities to control outbreaks, the narrative presented by public authorities within china that the virus was mainly an overseas problem as well as some doctors within china who warned vulnerable people of the health risks of the vaccine. doses of covid-19 vaccine administrated in mainland china as ofdoses administrated(in million)